Cosmos Pharmaceutical Corp

Common Name

Cosmos Pharmaceutical

Country

Japan

Sector

Healthcare

Industry

Pharmaceutical Retailers

Employees

5,709

Ticker

3349

Exchange

TOKYO STOCK EXCHANGE

Website

www.cosmospc.co.jp

Description

Cosmos Pharmaceutical Corp. is a leading entity in the pharmaceutical retail sector, predominantly operating in Japan. The company's core purpose lies in the management and operation of drugstore chai... Show more

Financial Statements of Cosmos Pharmaceutical

Below are the financial statements of Cosmos Pharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of JPY	2024	2023
Assets	—	—
Current assets	154,333^a	137,085^a
Cash and deposits	52,301^a	45,928^a
Accounts receivable	637^a	452^a
Merchandise	85,821^a	77,253^a
Supplies	352^a	226^a
Prepaid expenses	2,568^a	2,429^a
Accrued income	11,562^a	9,769^a
Other	1,089^a	1,025^a
Non-current assets	322,213^a	283,881^a
Property, plant and equipment	295,798^a	259,464^a
Intangible assets	497^a	547^a
Investments and other assets	25,917^a	23,869^a
Total assets	476,546^a	420,967^a
Liabilities	—	—
Current liabilities	213,229^a	192,053^a
Accounts payable	179,549^a	161,852^a
Short-term borrowings	4,581^a	2,741^a
Lease liabilities	1,931^a	1,744^a
Other payables	9,822^a	10,512^a
Accrued expenses	8,057^a	7,272^a
Accrued income taxes	5,572^a	5,031^a
Accrued consumption taxes	2,026^a	1,244^a
Contract liabilities	522^a	519^a
Provision for store closure losses	112^a	223^a
Other	1,052^a	909^a
Non-current liabilities	31,874^a	17,842^a
Long-term borrowings	23,385^a	10,018^a
Lease liabilities	4,166^a	3,698^a
Retirement benefit liabilities	1,751^a	1,636^a
Asset retirement obligations	2,141^a	2,028^a
Other	429^a	459^a
Total liabilities	245,104^a	209,895^a
Equity	—	—
Shareholders' equity	231,339^a	211,031^a
Capital stock	4,178^a	4,178^a
Capital surplus	5,101^a	4,610^a
Retained earnings	222,284^a	202,485^a
Treasury stock	-225^a	-242^a
Accumulated other comprehensive income	102^a	40^a
Valuation difference on available-for-sale securities	1^a	1^a
Cumulative adjustments related to retirement benefits	101^a	39^a
Total equity	231,442^a	211,072^a
Total liabilities and equity	476,546^a	420,967^a

Verified Sources Behind Cosmos Pharmaceutical’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Cosmos Pharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Cosmos Pharmaceutical's Integrated Report 2024

Trace every data point back to Cosmos Pharmaceutical’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Cosmos Pharmaceutical Corp

Financial Statements of Cosmos Pharmaceutical

Verified Sources Behind Cosmos Pharmaceutical’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Sugi Holdings Co Ltd

Sundrug Co Ltd

Kyowa Kirin Co Ltd

Ono Pharmaceutical Co Ltd

Sysmex Corp

Shionogi & Co Ltd